These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11927038)

  • 41. Ofloxacin-resistant Vibrio cholerae O139 in Hong Kong.
    Kam KM; Luey KY; Cheung TL; Ho KY; Mak KH; Saw PT
    Emerg Infect Dis; 1999; 5(4):595-7. PubMed ID: 10458975
    [No Abstract]   [Full Text] [Related]  

  • 42. Susceptibility to rifaximin of Vibrio cholerae strains from different geographical areas.
    Scrascia M; Forcillo M; Maimone F; Pazzani C
    J Antimicrob Chemother; 2003 Aug; 52(2):303-5. PubMed ID: 12837732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Seasonal fluctuations in the antibiotic sensitivity of Vibrio cholerae].
    Andrusenko IT; Pasternak NA; Givental' NI; Ved'mina EA; Shepelev AP
    Antibiot Med Biotekhnol; 1987 Apr; 32(4):275-9. PubMed ID: 3631933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative study of the epidemiology of cholera and sensitivity to antibiotics of strains collected during the epidemiological period in 1971 and 1972 in Wilaya de Constantine].
    Stefkov AS; Mered B
    God Zb Med Fak Skopje; 1975; 21():133-42. PubMed ID: 1213515
    [No Abstract]   [Full Text] [Related]  

  • 45. [Analysis of monitoring results for Vibrio cholerae in Wuzhou city from 2009 to 2010].
    Liao X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Oct; 32(10):1050-1. PubMed ID: 22991708
    [No Abstract]   [Full Text] [Related]  

  • 46. Emergence of nalidixic acid resistant Vibrio cholerae O-1 in Karachi.
    Mahmood A
    J Pak Med Assoc; 1999 Nov; 49(11):286. PubMed ID: 10647244
    [No Abstract]   [Full Text] [Related]  

  • 47. Vibrio cholerae--Truk, Federated States of Micronesia.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Oct; 31(39):539. PubMed ID: 6817052
    [No Abstract]   [Full Text] [Related]  

  • 48. Variation in polymyxin sensitivity among colonies in primary plate cultures of Vibrio eltor.
    Gugnani HC; Pal SC
    J Med Microbiol; 1974 Nov; 7(4):535-6. PubMed ID: 4375195
    [No Abstract]   [Full Text] [Related]  

  • 49. Sensitivity of vibrio group of organisms to minocycline--a new tetracycline derivative.
    Sanyal SC; Singh SJ; Sen PC
    Indian J Med Res; 1976 Dec; 64(12):1826-35. PubMed ID: 1024085
    [No Abstract]   [Full Text] [Related]  

  • 50. Alcohol and its influence on the survival of Vibrio cholerae.
    Guthrie JS; McKenzie H; Ho-Yen DO
    Br J Biomed Sci; 2007; 64(2):91-3. PubMed ID: 17633146
    [No Abstract]   [Full Text] [Related]  

  • 51. Can Etest be used to determine Vibrio cholerae susceptibility to erythromycin?
    Ng LK; Sawatzky P; Galas M; Rodrigues Ddos P; Heitmann I; Fernandez S; Bolmström A
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1479-80. PubMed ID: 12654699
    [No Abstract]   [Full Text] [Related]  

  • 52. Chlorine and survival of "rugose" Vibrio cholerae.
    Rice EW; Johnson CJ; Clark RM; Fox KR; Reasoner DJ; Dunnigan ME; Panigrahi P; Johnson JA; Morris JG
    Lancet; 1992 Sep; 340(8821):740. PubMed ID: 1355849
    [No Abstract]   [Full Text] [Related]  

  • 53. Cholera in Madagascar.
    Duval P; Champetier de Ribes G; Ranjalahy J; Quilici ML; Fournier JM
    Lancet; 1999 Jun; 353(9169):2068. PubMed ID: 10376637
    [No Abstract]   [Full Text] [Related]  

  • 54. Phage predation, disease severity and pathogen genetic diversity in cholera patients.
    Madi N; Cato ET; Sayeed MA; Creasy-Marrazzo A; Cuénod A; Islam K; Khabir MIU; Bhuiyan MTR; Begum YA; Freeman E; Vustepalli A; Brinkley L; Kamat M; Bailey LS; Basso KB; Qadri F; Khan AI; Shapiro BJ; Nelson EJ
    bioRxiv; 2024 Mar; ():. PubMed ID: 37398242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: a systematic review and meta-analysis.
    Ahmadi MH
    Antimicrob Resist Infect Control; 2021 Aug; 10(1):115. PubMed ID: 34362438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimating effectiveness of case-area targeted response interventions against cholera in Haiti.
    Michel E; Gaudart J; Beaulieu S; Bulit G; Piarroux M; Boncy J; Dely P; Piarroux R; Rebaudet S
    Elife; 2019 Dec; 8():. PubMed ID: 31886768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered Integrative and Conjugative Elements (ICEs) in Recent
    Sarkar A; Morita D; Ghosh A; Chowdhury G; Mukhopadhyay AK; Okamoto K; Ramamurthy T
    Front Microbiol; 2019; 10():2072. PubMed ID: 31555253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial resistance of
    Mohammed Y; Aboderin AO; Okeke IN; Olayinka AT
    Afr J Lab Med; 2018; 7(2):778. PubMed ID: 30643734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing sociocultural features of cholera in three endemic African settings.
    Schaetti C; Sundaram N; Merten S; Ali SM; Nyambedha EO; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
    BMC Med; 2013 Sep; 11():206. PubMed ID: 24047241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis.
    Reveiz L; Chapman E; Ramon-Pardo P; Koehlmoos TP; Cuervo LG; Aldighieri S; Chambliss A
    PLoS One; 2011; 6(11):e27060. PubMed ID: 22102873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.